Samsung Biologics Co
300, Songdo bio-daero, Yeonsu-gu,
Incheon, 21987,
South Korea
Incheon, 21987,
South Korea
82 32-455-3114
Life Sciences
Samsung Biologics Co Technographics
Samsung Biologics Co Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Samsung Biologics Co and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 4400 Samsung Biologics Co employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Samsung Biologics Co has purchased the following applications: In-House ERP for ERP Financial in 2021, Microsoft Power BI for Analytics and BI in 2021, Microsoft 365 for Collaboration in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Samsung Biologics Co is running and its propensity to invest more and deepen its relationship with In-House Applications , Microsoft , Veeva Systems or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Samsung Biologics Co revenues, which have grown to $1.20 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Samsung Biologics Co intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Samsung Biologics Co Tech Stack and Enterprise Applications
ERP Financial Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| In-House Applications | Legacy | In-House ERP | ERP Financial | ERP Financial Management | n/a | 2021 | 2022 |
In 2021, Samsung Biologics Co implemented In-House ERP in the ERP Financial category. The in-house application was provisioned as a centralized finance core to standardize accounting and financial management across corporate finance and statutory reporting, and it serves as the primary financial system for the company.
The implementation focused on ERP Financial functional modules, including general ledger, accounts payable, accounts receivable, fixed assets, treasury, tax management, intercompany accounting, period close orchestration, and financial reporting. Configuration work emphasized a unified chart of accounts, master data governance, automated approval workflows, and role based access controls to align finance process flows with corporate policy and compliance requirements.
Architecturally the In-House ERP was delivered as an internal application stack with a centralized database and application tier to manage transactional and master financial data. Integration patterns rely on batch interfaces and APIs to bring operational transactions and external data feeds into the finance core, while governance was organized under centralized finance process ownership with change control, phased module rollout, and end user training to operationalize the ERP Financial platform.
|
Analytics and BI
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft Power BI | Analytics and BI | Analytics and BI | n/a | 2021 | 2021 |
In 2021, Samsung Biologics Co deployed Microsoft Power BI as a central element of its Analytics and BI capabilities to consolidate reporting and dashboarding across IT data functions. The initiative was led from the IT Data Group and the IT Data Digitalization Group in Incheon, South Korea, aligning BI workstreams with existing data architecture and enterprise data warehouse efforts.
The Microsoft Power BI deployment was implemented alongside an Azure native data pipeline stack, including Azure Data Factory for ETL and an enterprise data warehouse for modeled datasets. Implementation work emphasized curated data models, report authoring, scheduled data refresh and distribution using Power BI service features, with Power Automate and M365 used to support report delivery and collaboration workflows.
Integrations explicitly included Microsoft Azure platform components, Azure Data Factory, EDW constructs, SQL based data sources, Power Automate and M365, creating an end to end flow from ETL to self service and governed reporting. Operational coverage focused on the IT Data Group and the Data Digitalization Group, with analytics support services and authored dashboards governing consumption by downstream IT and analytics stakeholders.
Governance and operating model adjustments were driven by the IT Data Group Leader roles active during 2021, which covered EDW, ADF, Power BI, Power Automate and related M365 governance. Controls emphasized centralized data models, BI lifecycle management, and role based report stewardship to ensure consistent metadata and reporting practices within the Analytics and BI environment.
|
|
|
|
|
Process Mining | Analytics and BI |
|
2021 | 2021 |
|
Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2021 | 2021 |
In 2021, Samsung Biologics Co implemented Microsoft 365 as its primary Collaboration platform. The rollout targeted IT and data organizations based in Incheon South Korea and extended collaboration capabilities to enterprise users, aligning the deployment with IT Data Digitalization and infrastructure management priorities.
The Microsoft 365 deployment configured core Collaboration components including Microsoft Teams for synchronous collaboration, Exchange Online for email, SharePoint Online for document management, and OneDrive for personal file sync. Automation and workflow capabilities were enabled through Power Automate and analytics tied to collaboration activity were surfaced with Power BI, integrating collaboration workflows with existing data processes.
Integrations connected Microsoft 365 to Microsoft Azure and Azure Active Directory for identity and access management, and linked collaboration content into the enterprise EDW and Azure Data Factory pipelines for reporting and data integration. Operational ownership involved infrastructure teams responsible for Active Directory, operating system and network administration, asset management, and database support to maintain tenant stability and integrations.
Governance and process changes were led by the IT Data Digitalization Group, which incorporated data architecture and product data management practices into collaboration governance and established lifecycle controls for document stores and Teams workspaces. Administration was centralized with automated workflow patterns via Power Automate and analytics via Power BI to align Microsoft 365 Collaboration capabilities with enterprise data workflows.
|
Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Document Management | Content Management |
|
2020 | 2020 |
|
CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Marketing Analytics | CRM |
|
2016 | 2016 |
|
|
|
|
|
Marketing Automation | CRM |
|
2018 | 2018 |
|
|
|
|
|
Sales Automation, CRM, Sales Engagement | CRM |
|
2018 | 2018 |
|
|
|
|
|
Tag Management | CRM |
|
2020 | 2020 |
|
PLM and Engineering
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Quality Management | PLM and Engineering |
|
2020 | 2020 |
|
PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Apps Development | PaaS |
|
2021 | 2021 |
|
IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Identity and Access Management (IAM) | CyberSecurity |
|
2022 | 2022 |
|
|
|
|
|
Identity and Access Management (IAM) | CyberSecurity |
|
2022 | 2022 |
|
|
|
|
|
Secure Sockets Layer (SSL) | CyberSecurity |
|
2022 | 2022 |
|
|
|
|
|
Web Application Firewalls (WAF) | CyberSecurity |
|
2021 | 2021 |
|
IT Decision Makers and Key Stakeholders at Samsung Biologics Co
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Samsung Biologics Co Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Samsung Biologics Co IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Samsung Biologics Co digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Samsung Biologics Co Technographics
Samsung Biologics Co is a Life Sciences organization based in South Korea,
with around 4400 employees and annual revenues of $1.20 billion.
Samsung Biologics Co operates a diverse technology stack with applications such as
In-House ERP, Microsoft Power BI and Microsoft 365,
covering areas like ERP Financial, Analytics and BI and Collaboration.
Samsung Biologics Co has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as In-House Applications and Microsoft.
Samsung Biologics Co recently adopted applications including
Google Identity Platform in 2022, SailPoint Identity Platform in 2022 and Sectigo SSL in 2022,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Samsung Biologics Co’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Samsung Biologics Co’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Samsung Biologics Co technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.